Evidence map›Paper›PMID 38502279›Full record

ReviewTissue engineering and regenerative medicine2024

Advancements in Human Embryonic Stem Cell Research: Clinical Applications and Ethical Issues.

Soo Jin Park, Yoon Young Kim, Ji Yeon Han, Sung Woo Kim, Hoon Kim, Seung-Yup Ku

Abstract readReview
In one paragraph

Review in Tissue engineering and regenerative medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Blood Pharming of Red Cells.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2026
    Review
  3. Article
  4. Article
  5. [Current status of intrauterine adhesion treatment and research progress in stem cell therapy].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. The role of stem cells in precision medicine: next-generation cancer treatment.Journal of the Egyptian National Cancer Institute · 2025
    Review
  12. Review
  13. Biomaterials and cell-based therapy post spinal cord injury.Journal of translational medicine · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Soo Jin ParkDepartment of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Republic of Korea.ORCID 0000-0002-7382-230X
Yoon Young KimDepartment of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Republic of Korea.ORCID 0000-0003-0671-519X
Ji Yeon HanDepartment of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Republic of Korea.ORCID 0000-0002-1007-3188
Sung Woo KimDepartment of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Republic of Korea.ORCID 0000-0003-4689-1323
Hoon KimDepartment of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Republic of Korea.ORCID 0000-0002-5623-6368
Seung-Yup KuDepartment of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Republic of Korea. jyhsyk@snu.ac.kr.ORCID 0000-0002-6423-854X

Funding

Korea Health Industry Development Institute HI22C1424Ministry of Science and ICT, South Korea 2020R1A2C1010293
6 · The paper itself

Abstract

backgroundThe development and use of human embryonic stem cells (hESCs) in regenerative medicine have been revolutionary, offering significant advancements in treating various diseases. These pluripotent cells, derived from early human embryos, are central to modern biomedical research. However, their application is mired in ethical and regulatory complexities related to the use of human embryos.

methodThis review utilized key databases such as ClinicalTrials.gov, EU Clinical Trials Register, PubMed, and Google Scholar to gather recent clinical trials and studies involving hESCs. The focus was on their clinical application in regenerative medicine, emphasizing clinical trials and research directly involving hESCs.

resultsPreclinical studies and clinical trials in various areas like ophthalmology, neurology, endocrinology, and reproductive medicine have demonstrated the versatility of hESCs in regenerative medicine. These studies underscore the potential of hESCs in treating a wide array of conditions. However, the field faces ethical and regulatory challenges, with significant variations in policies and perspectives across different countries.

conclusionThe potential of hESCs in regenerative medicine is immense, offering new avenues for treating previously incurable diseases. However, navigating the ethical, legal, and regulatory landscapes is crucial for the continued advancement and responsible application of hESC research in the medical field. Considering both scientific potential and ethical implications, a balanced approach is essential for successfully integrating hESCs into clinical practice.

Indexed as

Human Embryonic Stem CellsHumansRegenerative MedicineStem Cell ResearchClinical trialsEthicsHuman embryonic stem cellsMedicalRegenerative medicineStem cell research

Identifiers

PMID38502279
PMCPMC10987435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.